Open Clinical Trials

We currently have three open clinical trials at Celilo Cancer Center and are actively looking to recruit patients that are interested and for whom they are appropriate.  If interested, please contact Symantha McClennan, Clinical Trials Associate at symantham@mcmc.net for more information.

CALBG 30610: A Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with  Limited Small Cell Lung Cancer also receiving Cisplatin or Carboplatin and Etoposide.

NSABP B-51: A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patient with Positive Axillary Nodes Before Neoadjuvant Chemotherapy who Convert to Pathologically Negative Axillary Nodes after Neoadjuvant Chemotherapy.

RTOG 0848: A Phase II-R and a Phase III Trial Evaluating both Eriotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma.

Contact Us

Celilo Cancer Center

1800 E. 19th St, The Dalles, OR

Ph: 541-296-7585